The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumInterviews - Ventrus Biosciences (NASDAQ:VTUS) believes it has hit the “trifecta of anal fissure endpoints” with its lead candidate VEN-307. In a 465 patient Phase III trial, CEO … Continue Reading
Read nowLong Ideas - By Jake King Merge Healthcare Inc. (NASDAQ:MRGE) could be seeing the first round of corporate bids next week, according to dealReporter. Offers to buy the company, … Continue Reading
Read nowLong Ideas - Exelixis (NASDAQ:EXEL) Thursday is retracing some of its losses from the beginning of the week and is up 10% from yesterday’s close, to $5.00, due … Continue Reading
Read nowLong Ideas - Achillion Pharmaceuticals (NASDAQ:ACHN) is up nearly 80% since its summer lows (see our initial article on ACHN here), as the hepatitis C (HCV) space continues … Continue Reading
Read nowMost Popular - A bearish article from theStreet.com is pressuring shares of Hemispherx Biopharma (NASDAQ:HEB) Thursday morning, which comes shortly after the company announced a December 20th FDA … Continue Reading
Read nowMost Popular - Peregrine Pharmaceuticals (NASDAQ:PPHM) announced more bad news Thursday, after receiving a default notice from lender, Oxford Finance, on Monday. The default on the loan was … Continue Reading
Read nowLong Ideas - On Tuesday, Vertex Pharmaceuticals (NASDAQ:VRTX) announced that while it would be advancing its developmental Hepatitis C (HCV) treatment, ALS-2200, into Phase II testing, ALS-2158 didn’t … Continue Reading
Read now
